<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPH</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Public Health Surveill</journal-id>
      <journal-title>JMIR Public Health and Surveillance</journal-title>
      <issn pub-type="epub">2369-2960</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v7i7e27621</article-id>
      <article-id pub-id-type="pmid">34255695</article-id>
      <article-id pub-id-type="doi">10.2196/27621</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Performance of the Severe Acute Respiratory Illness Sentinel Surveillance System in Yemen: Mixed Methods Evaluation Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Algunaid</surname>
            <given-names>Magid</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Lami</surname>
            <given-names>Faris</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Taha</surname>
            <given-names>Hana</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Bright</surname>
            <given-names>Roselie</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Alkholidy</surname>
            <given-names>Ghamdan Gamal</given-names>
          </name>
          <degrees>MBBS</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <address>
            <institution>Yemen Field Epidemiology Training Program</institution>
            <institution>Ministry of Public Health and Population</institution>
            <addr-line>Alsteen St, Bldg 23</addr-line>
            <addr-line>Sana'a</addr-line>
            <country>Yemen</country>
            <phone>967 771530764</phone>
            <email>ghamdangamal@gmail.com</email>
          </address>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-0991-0185</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author">
          <name name-style="western">
            <surname>Anam</surname>
            <given-names>Labiba Saeed</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-7927-4503</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Almahaqri</surname>
            <given-names>Ali Hamoud</given-names>
          </name>
          <degrees>BSc</degrees>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-3776-3311</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Khader</surname>
            <given-names>Yousef</given-names>
          </name>
          <degrees>ScD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-7830-6857</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Yemen Field Epidemiology Training Program</institution>
        <institution>Ministry of Public Health and Population</institution>
        <addr-line>Sana'a</addr-line>
        <country>Yemen</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>National Influenza Control Program</institution>
        <institution>Ministry of Public Health and Population</institution>
        <addr-line>Sana'a</addr-line>
        <country>Yemen</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Department of Community Medicine, Public Health and Family Medicine</institution>
        <institution>Faculty of Medicine</institution>
        <institution>Jordan University of Science &#38; Technology</institution>
        <addr-line>Irbidjord</addr-line>
        <country>Jordan</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Ghamdan Gamal Alkholidy <email>ghamdangamal@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <volume>7</volume>
      <issue>7</issue>
      <elocation-id>e27621</elocation-id>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>1</month>
          <year>2021</year>
        </date>
        <date date-type="rev-request">
          <day>6</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>4</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>5</month>
          <year>2021</year>
        </date>
      </history>
      <copyright-statement>©Ghamdan Gamal Alkholidy, Labiba Saeed Anam, Ali Hamoud Almahaqri, Yousef Khader. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 09.07.2021.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://publichealth.jmir.org/2021/7/e27621" xlink:type="simple"/>
      <abstract>
        <sec sec-type="background">
          <title>Background</title>
          <p>The national severe acute respiratory illness (SARI) surveillance system in Yemen was established in 2010 to monitor SARI occurrence in humans and provide a foundation for detecting SARI outbreaks.</p>
        </sec>
        <sec sec-type="objective">
          <title>Objective</title>
          <p>To ensure that the objectives of national surveillance are being met, this study aimed to examine the level of usefulness and the performance of the SARI surveillance system in Yemen.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>The updated Centers for Disease Control and Prevention guidelines were used for the purposes of our evaluation. Related documents and reports were reviewed. Data were collected from 4 central-level managers and stakeholders and from 10 focal points at 4 sentinel sites by using a semistructured questionnaire. For each attribute, percent scores were calculated and ranked as follows: very poor (≤20%), poor (20%-40%), average (40%-60%), good (60%-80%), and excellent (&#62;80%).</p>
        </sec>
        <sec sec-type="results">
          <title>Results</title>
          <p>As rated by the evaluators, the SARI surveillance system achieved its objectives. The system’s flexibility (percent score: 86%) and acceptability (percent score: 82%) were rated as “excellent,” and simplicity (percent score: 74%) and stability (percent score: 75%) were rated as “good.” The percent score for timeliness was 23% in 2018, which indicated poor timeliness. The overall data quality percent score of the SARI system was 98.5%. Despite its many strengths, the SARI system has some weaknesses. For example, it depends on irregular external financial support.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusions</title>
          <p>The SARI surveillance system was useful in estimating morbidity and mortality, monitoring the trends of the disease, and promoting research for informing prevention and control measures. The overall performance of the SARI surveillance system was good. We recommend expanding the system by promoting private health facilities’ (eg, private hospitals and private health centers) engagement in SARI surveillance, establishing an electronic database at central and peripheral sites, and providing the National Central Public Health Laboratory with the reagents needed for disease confirmation.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>evaluation</kwd>
        <kwd>surveillance</kwd>
        <kwd>Centers for Disease Control and Prevention guidelines</kwd>
        <kwd>severe acute respiratory illness</kwd>
        <kwd>Yemen</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <p>Worldwide, acute lower respiratory infection is the second commonest cause of morbidity and the third commonest cause of mortality in all age groups [<xref ref-type="bibr" rid="ref1">1</xref>]. A significant proportion of the global burden of acute lower respiratory infection, especially in children and older adults, is attributable to influenza and respiratory syncytial viruses.</p>
      <p>The World Health Organization (WHO) estimated that worldwide annual influenza epidemics result in about 3 million to 5 million cases of severe illness and about 250,000 to 500,000 deaths. In early 2019, the Global Burden of Disease study estimated that 99,000 to 200,000 annual deaths resulting from lower respiratory tract infections are directly attributable to influenza [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>].</p>
      <p>Estimates are rare in many countries, including countries in the Eastern Mediterranean Region. The influenza A (H1N1) pandemic highlighted the necessity of reliable estimates for the disease burden of severe acute respiratory illness (SARI) and influenza-associated SARI (F-SARI) in all countries and regions of the world [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
      <p>Many countries have established sentinel sites for influenza epidemiological surveillance. The data captured from sentinel sites have been used by WHO member states to estimate disease burden at the national level and to compare data between countries.</p>
      <p>Due to the fact that many emerging and reemerging diseases classified under the International Health Regulations are of an acute respiratory nature (eg, SARS [severe acute respiratory syndrome], MERS-CoV [Middle East respiratory syndrome coronavirus], and novel influenza pathogens such as H5N1 and H7N7), it is necessary to strengthen surveillance systems for acute respiratory infections and influenza in all WHO member states. This will enable countries to produce more accurate estimations of SARI and F-SARI burden [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>].</p>
      <p>Based on the Worldometer elaboration of the latest United Nations data in 2020, the current population size of Yemen is 29,771,764 [<xref ref-type="bibr" rid="ref4">4</xref>]. Yemen has 4 seasons, but it is likely that the influenza virus is being circulated throughout the year. Thus, there is a great probability that different patterns of influenza virus circulation occur throughout the year [<xref ref-type="bibr" rid="ref5">5</xref>]. Yemen is one of the countries that experience a high number of deaths resulting from acute and chronic respiratory infections. In 2008, the Ministry of Public Health and Population initiated the National Influenza Control Program to enhance the country’s capacity in monitoring influenza diseases among community, guide the country in reducing morbidity and mortality from influenza diseases through the early detection of emerging novel influenza subtypes, provide a timely response for influenza prevention and control, and provide recommendations for improving influenza surveillance.</p>
      <p>In 2013, more than 250 cases of influenza and 10 deaths were reported. A total of 1811 patients with SARI were admitted from 2011 to 2016. Of these patients, 1413 (78%) were aged &#60;15 years, 89 (4.9%) patients had influenza viruses, and 655 (36.2%) had noninfluenza viruses. Further, the case fatality rate was 8% [<xref ref-type="bibr" rid="ref6">6</xref>].</p>
      <p>The Surveillance Department of the Ministry of Public Health proposed the inclusion of influenza in the Joint Program Review and Planning Mission [<xref ref-type="bibr" rid="ref6">6</xref>]. The Central Public Health Laboratory was recognized as a national influenza center where facilities for carrying out polymerase chain reaction and serology tests are available and functional [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>].</p>
      <p>The WHO recommends that countries should perform surveillance for SARI and F-SARI and that surveillance systems should undergo periodic comprehensive evaluations. To ensure that the objectives of national surveillance are being met, this study aimed to examine the level of usefulness and the performance of the SARI surveillance system.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Study Design</title>
        <p>A descriptive study was conducted to evaluate the SARI surveillance system from October to December 2018 based on the updated Centers for Disease Control and Prevention guidelines for the evaluation of a public health surveillance system [<xref ref-type="bibr" rid="ref8">8</xref>]. Mixed methods with quantitative and qualitative components were used for the evaluation. SARI sentinel sites at four public hospitals—Al Joumhouri, Al Wahda, Al Swaide, and Al Thawra—in four governorates (Sana’a city, Aden, Taiz, and Al Hodeida) were studied. All possible stakeholders, including National Influenza Control Program managers, data entry staff, Ministry of Public Health and Population staff, and members of focal points in sentinel sites, were enrolled in this study.</p>
      </sec>
      <sec>
        <title>Data Collection</title>
        <p>A desk review of all documents, guidelines, strategies, and pertinent scientific literature on influenza programs was conducted. Data were collected via in-depth interviews and semistructured questionnaires (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>) with stakeholders and members of focal points at the sentinel sites, respectively. In addition, a review of the SARI system database was conducted.</p>
      </sec>
      <sec>
        <title>System Attributes</title>
        <p>A total of 9 surveillance system attributes that can affect usefulness were assessed. Quantitative analysis was used to assess data quality, timeliness, sensitivity, and positive predictive values. Qualitative analysis was used to assess representativeness, simplicity, flexibility, acceptability, and stability.</p>
      </sec>
      <sec>
        <title>Analysis Methods</title>
        <p>To determine the level of usefulness, the system was considered useful if it met at least one of its objectives and one of its planned uses. With regard to qualitative attributes, stakeholders were asked to rate the degree to which they agreed with attributes’ specific indicators by using a 5-point Likert scale (1=strongly disagree; 2=disagree; 3=neutral; 4=agree; 5=strongly agree). Higher scores indicated better performance in terms of the studied attribute. The scores of all indicators for each attribute were summed and divided by the maximum scores to produce a percent score. The percent score was used to rank each attribute. The final rank of each attribute was classified as follows: excellent (attribute score: &#62;80%), good (attribute score: 60%-80%), average (attribute score: 40%-60%), poor (attribute score: 20%-40%), and very poor (attribute score: ≤20%).</p>
        <p>With regard to quantitative attributes, data quality was assessed by measuring the completeness of patient interview forms, form transmission data, and respiratory specimen collection and testing data and by checking signs and symptoms records and primary diagnoses to determine whether surveillance case definitions had been adhered to properly. The data collected by the system were compared against the minimum data collection standards for SARI surveillance. Timeliness was assessed by calculating the percentage of specimens that were collected and sent to the laboratory within 72 hours.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Findings From the Desk Review for Describing the SARI System</title>
        <sec>
          <title>The Main Purpose and Objectives of the SARI System</title>
          <p>The National Influenza Sentinel Surveillance system was established in 2010. The main purpose and objectives of the SARI system are to monitor influenza occurrence in humans and to provide a foundation for detecting outbreaks of novel strains of influenza.</p>
        </sec>
        <sec>
          <title>SARI Case Definition</title>
          <p>A case of SARI was defined as a person meeting the case definition of influenza-like illness (ie, the sudden onset of a fever of &#62;38 °C and at least 1 of the following respiratory symptoms: dry cough, sore throat in the absence of another diagnosis, and shortness of breath or difficulty in breathing requiring hospital admission).</p>
        </sec>
        <sec>
          <title>Sources of Data for the SARI System</title>
          <p>Surveillance for influenza-like illness and SARI was carried out in 4 sentinel sites. Aggregated data were collected from and reported by each sentinel site. The data included the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>the number of new SARI cases during the reported week</p>
            </list-item>
            <list-item>
              <p>the number of new SARI cases in which specimens were collected during the reported week</p>
            </list-item>
            <list-item>
              <p>the total number of new hospital admissions to wards in which SARI surveillance is being conducted</p>
            </list-item>
            <list-item>
              <p>specimen and epidemiological data</p>
            </list-item>
          </list>
          <p>Specimens and epidemiological data are collected from the sentinel sites and transported to national public health laboratories. At the laboratory, specimens are tested for the influenza A and B viruses and are further subtyped if they test positive for the influenza A virus. Epidemiological and virological data collected from the sentinel sites should be collected and reported regularly to the national health authorities on a weekly basis throughout the year.</p>
        </sec>
        <sec>
          <title>Data Flow and Feedback in the SARI Surveillance System</title>
          <p>The system was designed so that each sentinel site could send its reports to central sites within 1 week. Further, samples sent to National Central Public Health laboratories within 72 hours are sent to US Naval Medical Research Unit Number 3 for confirmation, as shown in <xref rid="figure1" ref-type="fig">Figure 1</xref>. At the central sites, data are reviewed, organized, and analyzed, as required. Feedback is then sent to sentinel sites.</p>
          <fig id="figure1" position="float">
            <label>Figure 1</label>
            <caption>
              <p>This figure illustrates the data flow and feedback in the influenza-like illness and SARI surveillance program of the Ministry of Public Health and Population in Yemen. SARI: severe acute respiratory illness.</p>
            </caption>
            <graphic xlink:href="publichealth_v7i7e27621_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
          </fig>
        </sec>
      </sec>
      <sec>
        <title>Demographic Characteristics of the Participants</title>
        <p>A total of 3 persons at the central sites and 10 persons at the peripheral sites (3 pediatricians, 3 nurses, 2 laboratorian specialists, 3 health system directors, and 2 medical specialists) evaluated the system. The mean age of the participants was 44.5 years.</p>
      </sec>
      <sec>
        <title>Findings From In-depth Interviews at Central and Peripheral Sites</title>
        <sec>
          <title>Usefulness</title>
          <p>Of the 4 SARI stakeholders at the central sites, 3 (75%) agreed that the SARI surveillance system met its objectives. The usefulness percent score was 75%, indicating that the usefulness of the SARI system was good.</p>
        </sec>
        <sec>
          <title>Flexibility</title>
          <p>All 13 respondents agreed that the system could easily adapt to changes in the SARI case definition, include other diseases, and accommodate any changes in data with less effort and minimal costs. The overall percent score for flexibility was 86%, which indicated excellent performance (<xref ref-type="table" rid="table1">Table 1</xref>). At sentinel sites, the percent score, as determined by 10 stakeholders, was 71%. This indicated that the system had good performance at the peripheral sites.</p>
          <table-wrap position="float" id="table1">
            <label>Table 1</label>
            <caption>
              <p>Flexibility of the severe acute respiratory illness (SARI) surveillance system (N=13).<sup>a</sup></p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="640"/>
              <col width="120"/>
              <col width="120"/>
              <col width="120"/>
              <thead>
                <tr valign="top">
                  <td>Indicator</td>
                  <td>Total score</td>
                  <td>Percent score</td>
                  <td>Rank</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td>The system could adapt easily to changes in the SARI case definition</td>
                  <td>34</td>
                  <td>83</td>
                  <td>Excellent</td>
                </tr>
                <tr valign="top">
                  <td>The system can adapt to the integration of other surveillance systems</td>
                  <td>35</td>
                  <td>84</td>
                  <td>Excellent</td>
                </tr>
                <tr valign="top">
                  <td>The system adapted to accommodate new, additional information (eg, variation in resources)</td>
                  <td>41</td>
                  <td>90</td>
                  <td>Excellent</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="table1fn1">
                <p><sup>a</sup>The total score, percent score, and rank of the system were 120, 86, and excellent, respectively.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>Stability</title>
          <p>All 4 stakeholders at the central sites agreed that the system could adapt to changes in resources, but half of the stakeholders (2/4, 50%) stated that the system mainly depends on external funds. With regard to the scoring system, the overall stability percent score was 75% (<xref ref-type="table" rid="table2">Table 2</xref>). This indicated that the stability of the SARI system was good.</p>
          <table-wrap position="float" id="table2">
            <label>Table 2</label>
            <caption>
              <p>Stability of the severe acute respiratory illness system (n=4).<sup>a</sup></p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="640"/>
              <col width="120"/>
              <col width="120"/>
              <col width="120"/>
              <thead>
                <tr valign="top">
                  <td>Indicator</td>
                  <td>Total score</td>
                  <td>Percent score</td>
                  <td>Rank</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td>The system can adapt to changes in resources</td>
                  <td>4</td>
                  <td>100</td>
                  <td>Excellent</td>
                </tr>
                <tr valign="top">
                  <td>The system can adapt to funding withdrawal</td>
                  <td>2</td>
                  <td>50</td>
                  <td>Average</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="table2fn1">
                <p><sup>a</sup>The total score, percent score, and rank of the system were 6, 75, and good, respectively.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec>
        <title>Findings From the Self-Administered Semistructured Questionnaire for Sentinel Site Focal Points</title>
        <sec>
          <title>Simplicity</title>
          <p>In total, 2 indicators of simplicity were ranked as excellent, 3 were ranked as good, and 1 was ranked as average. The simplicity percent score of the system was 74% (<xref ref-type="table" rid="table3">Table 3</xref>), indicating that the SARI system’s simplicity attribute was good.</p>
          <table-wrap position="float" id="table3">
            <label>Table 3</label>
            <caption>
              <p>Simplicity of the severe acute respiratory illness (SARI) system based on total scores, percent scores, and rank.<sup>a</sup></p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="640"/>
              <col width="120"/>
              <col width="120"/>
              <col width="120"/>
              <thead>
                <tr valign="top">
                  <td>Indicator</td>
                  <td>Total score</td>
                  <td>Percent score</td>
                  <td>Rank</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td>There is the existence of a SARI case definition</td>
                  <td>30</td>
                  <td>60</td>
                  <td>Average</td>
                </tr>
                <tr valign="top">
                  <td>Using the SARI case definition is easy</td>
                  <td>37</td>
                  <td>74</td>
                  <td>Good</td>
                </tr>
                <tr valign="top">
                  <td>The SARI system uses an easy and understandable format</td>
                  <td>37</td>
                  <td>74</td>
                  <td>Good</td>
                </tr>
                <tr valign="top">
                  <td>Writing a SARI report does not take much time</td>
                  <td>40</td>
                  <td>80</td>
                  <td>Excellent</td>
                </tr>
                <tr valign="top">
                  <td>The trainees had training</td>
                  <td>42</td>
                  <td>80</td>
                  <td>Excellent</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="table3fn1">
                <p><sup>a</sup>The total score, percent score, and rank of the system were 186, 74, and good, respectively.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>Acceptability</title>
          <p>The two indicators of acceptability (ie, the willingness to participate among people within the system and satisfaction with the SARI surveillance system) were ranked as excellent. The acceptability percent score of the SARI system was 82% (ie, the SARI system had excellent performance; <xref ref-type="table" rid="table4">Table 4</xref>).</p>
          <table-wrap position="float" id="table4">
            <label>Table 4</label>
            <caption>
              <p>Acceptability of the severe acute respiratory illness (SARI) surveillance system among sentinel sites (n=10).<sup>a</sup></p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="640"/>
              <col width="120"/>
              <col width="120"/>
              <col width="120"/>
              <thead>
                <tr valign="top">
                  <td>Indicator</td>
                  <td>Total score</td>
                  <td>Percent score</td>
                  <td>Rank</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td>Are you willing to participate within the system?</td>
                  <td>40</td>
                  <td>80</td>
                  <td>Excellent</td>
                </tr>
                <tr valign="top">
                  <td>Are you satisfied with the SARI surveillance system?</td>
                  <td>42</td>
                  <td>84</td>
                  <td>Excellent</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="table4fn1">
                <p><sup>a</sup>The total score, percent score, and rank of the system were 82, 82, and excellent, respectively.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec>
        <title>Findings From the Review of the SARI System Database</title>
        <sec>
          <title>Data Quality</title>
          <p>Data quality was evaluated by assessing the percentage of complete forms and the missing variable data in the forms. All of the patients included in the central sites’ database (N=245) had complete forms (245 forms; 100% completeness). With regard to missing data, 22 case report forms from 2018 were selected randomly and reviewed. No missing variables were found, and the variables in these forms were in line with those of the database (completeness: 100%; accuracy: 97%). The overall data quality percent score was 98.5% (excellent).</p>
        </sec>
        <sec>
          <title>Timeliness</title>
          <p>The percentage of collected specimens at the health facilities that sent samples to the laboratory within 72 hours was used as an indicator of timeliness. Of the 182 collected samples, 42 (23.1%) samples were sent to the laboratory within 72 hours. The percent score for timeliness was 23% in 2018, indicating that the system’s timeliness was poor.</p>
        </sec>
      </sec>
      <sec>
        <title>Overall Performance of the SARI Surveillance System</title>
        <p>The overall performance of the SARI surveillance system had a percent score of 79% (ie, the SARI system had good performance; <xref ref-type="table" rid="table5">Table 5</xref>).</p>
        <table-wrap position="float" id="table5">
          <label>Table 5</label>
          <caption>
            <p>The overall performance of the severe acute respiratory illness system in Yemen.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="640"/>
            <col width="120"/>
            <col width="120"/>
            <col width="120"/>
            <thead>
              <tr valign="top">
                <td>Indicators</td>
                <td>Score</td>
                <td>Percent score</td>
                <td>Rank</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>Usefulness</td>
                <td>15</td>
                <td>75</td>
                <td>Good</td>
              </tr>
              <tr valign="top">
                <td>Flexibility</td>
                <td>120</td>
                <td>86</td>
                <td>Excellent</td>
              </tr>
              <tr valign="top">
                <td>Stability</td>
                <td>6</td>
                <td>75</td>
                <td>Good</td>
              </tr>
              <tr valign="top">
                <td>Simplicity</td>
                <td>186</td>
                <td>74</td>
                <td>Good</td>
              </tr>
              <tr valign="top">
                <td>Acceptability</td>
                <td>82</td>
                <td>82</td>
                <td>Excellent</td>
              </tr>
              <tr valign="top">
                <td>Timeliness</td>
                <td>23</td>
                <td>23</td>
                <td>Poor</td>
              </tr>
              <tr valign="top">
                <td>Data quality</td>
                <td>99</td>
                <td>99</td>
                <td>Excellent</td>
              </tr>
              <tr valign="top">
                <td>Overall performance</td>
                <td>394</td>
                <td>79</td>
                <td>Good</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Strengths and Weaknesses of the SARI Surveillance System</title>
        <p>Despite its many strengths, the SARI system has some weaknesses. For example, it depends on irregular external financial support. To act as a platform for the surveillance of other respiratory illnesses, the SARI surveillance system integrates an influenza-like illness surveillance system with the electronic Disease Early Warning System. This has several benefits. First, it allows for efficient laboratory data collection and transportation. Second, the SARI system uses resources more efficiently than other systems. These widespread benefits enhance the usefulness of the system and allow the system to meet its own surveillance objectives and address broader national priorities.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Principal Findings</title>
        <p>The surveillance systems at sentinel sites are tools for the early detection of disease, the monitoring of trends in the burden of diseases, and the generation of recommendations for the prevention and control of diseases. The evaluation of surveillance systems helps decision makers to set priorities for future planning, resource allocation, and future interventions for preventing the spread of diseases.</p>
        <p>Overall, this study showed that the performance of the SARI surveillance system was good. Studies from Zambia [<xref ref-type="bibr" rid="ref9">9</xref>] and the Democratic Republic of Congo [<xref ref-type="bibr" rid="ref10">10</xref>] have reported similar findings. The SARI system was found to be useful in detecting trends and signal changes in the occurrence of SARI, estimating the magnitude of morbidity and mortality related to SARI, and promoting research for informing prevention and control measures for SARI. Similarly, a previous evaluation in Zambia demonstrated the usefulness of the system [<xref ref-type="bibr" rid="ref9">9</xref>].</p>
        <p>The SARI surveillance system was shown to be simple. The case definition and case report forms were available and easy to use. Similarly, the simplicity of the SARI surveillance system was documented in previous evaluations conducted in the Democratic Republic of Congo [<xref ref-type="bibr" rid="ref10">10</xref>] and Zambia [<xref ref-type="bibr" rid="ref10">10</xref>].</p>
        <p>The SARI surveillance system’s flexibility was excellent. The system appeared to be able to adapt easily to changes in the SARI case definition and accommodate changes in data with less effort and minimal costs. This finding is consistent with the findings of a study from South Africa [<xref ref-type="bibr" rid="ref11">11</xref>]. However, it is not consistent with the findings of studies from Zambia [<xref ref-type="bibr" rid="ref9">9</xref>] and the Democratic Republic of Congo [<xref ref-type="bibr" rid="ref10">10</xref>], which reported that the flexibility of the evaluated systems ranged from moderate to good. The acceptability of the SARI system was excellent, as reflected by the willingness of stakeholders to participate in the system and their satisfaction with the SARI surveillance system.</p>
        <p>The stability of the SARI surveillance system was good. It was found that the system was stable and could adapt to changes in resources (eg, donors withdrawing their support). This finding is in line with the findings of previous studies from South Africa [<xref ref-type="bibr" rid="ref11">11</xref>], the Democratic Republic of Congo [<xref ref-type="bibr" rid="ref10">10</xref>], and Zambia [<xref ref-type="bibr" rid="ref9">9</xref>]. However, it is not in line with the findings of a study from Pakistan [<xref ref-type="bibr" rid="ref12">12</xref>], which reported average stability.</p>
        <p>Our findings showed that the timeliness of the SARI system was very poor. This might be due to the lack of laboratory components that are essential for sampling. Previous evaluations in South Africa [<xref ref-type="bibr" rid="ref11">11</xref>], China [<xref ref-type="bibr" rid="ref13">13</xref>], Zambia [<xref ref-type="bibr" rid="ref9">9</xref>], and the Democratic Republic of Congo [<xref ref-type="bibr" rid="ref10">10</xref>] reported moderate to good timeliness. The quality and completeness of SARI surveillance system data were excellent.</p>
      </sec>
      <sec>
        <title>Limitations</title>
        <p>We could not calculate positive predictive values and assess sensitivity because the samples have not been tested since 2016 due to a lack of reagents.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>Overall, the SARI surveillance system was useful in estimating morbidity and mortality, monitoring the trends of the disease, and promoting research for informing prevention and control measures. The overall performance of the SARI surveillance system was good. We recommended expanding the system by promoting private health facilities’ (eg, private hospitals and private health centers) engagement in SARI surveillance, establishing an electronic database at central and peripheral sites, and providing the National Central Public Health Laboratory with the reagents needed for disease confirmation.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>Questionnaire.</p>
        <media xlink:href="publichealth_v7i7e27621_app1.docx" xlink:title="DOCX File , 107 KB"/>
      </supplementary-material>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">F-SARI</term>
          <def>
            <p>influenza-associated severe acute respiratory illness</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">MERS-CoV</term>
          <def>
            <p>Middle East respiratory syndrome coronavirus</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">SARI</term>
          <def>
            <p>severe acute respiratory illness</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">SARS</term>
          <def>
            <p>severe acute respiratory syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">WHO</term>
          <def>
            <p>World Health Organization</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>The authors would like acknowledge the Global Health Development/Eastern Mediterranean Public Health Network for their technical support.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <collab>GBD 2016 Lower Respiratory Infections Collaborators</collab>
          </person-group>
          <article-title>Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016</article-title>
          <source>Lancet Infect Dis</source>
          <year>2018</year>
          <month>11</month>
          <volume>18</volume>
          <issue>11</issue>
          <fpage>1191</fpage>
          <lpage>1210</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(18)30310-4"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/S1473-3099(18)30310-4</pub-id>
          <pub-id pub-id-type="medline">30243584</pub-id>
          <pub-id pub-id-type="pii">S1473-3099(18)30310-4</pub-id>
          <pub-id pub-id-type="pmcid">PMC6202443</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Paget</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Spreeuwenberg</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Charu</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Iuliano</surname>
              <given-names>AD</given-names>
            </name>
            <name name-style="western">
              <surname>Bresee</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Simonsen</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Viboud</surname>
              <given-names>C</given-names>
            </name>
            <collab>Global Seasonal Influenza-associated Mortality Collaborator NetworkGLaMOR Collaborating Teams*</collab>
          </person-group>
          <article-title>Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project</article-title>
          <source>J Glob Health</source>
          <year>2019</year>
          <month>12</month>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>020421</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://doi.org/10.7189/jogh.09.020421"/>
          </comment>
          <pub-id pub-id-type="doi">10.7189/jogh.09.020421</pub-id>
          <pub-id pub-id-type="medline">31673337</pub-id>
          <pub-id pub-id-type="pii">jogh-09-020421</pub-id>
          <pub-id pub-id-type="pmcid">PMC6815659</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gouya</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Rezaei</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Haghdoost</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Nabavi</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Farahi</surname>
              <given-names>KS</given-names>
            </name>
            <name name-style="western">
              <surname>Mostafavi</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Azad</surname>
              <given-names>TM</given-names>
            </name>
            <name name-style="western">
              <surname>Akbari</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Soroush</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Riazi</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Bitaraf</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Dadras</surname>
              <given-names>MN</given-names>
            </name>
            <name name-style="western">
              <surname>Barati</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Shakoori</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Bathaei</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Rezvani</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Hemmati</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Estimation of influenza and severe acute respiratory illness incidence (burden) in three provinces of the Islamic Republic of Iran, 2012 and 2013</article-title>
          <source>East Mediterr Health J</source>
          <year>2016</year>
          <month>10</month>
          <day>02</day>
          <volume>22</volume>
          <issue>7</issue>
          <fpage>432</fpage>
          <lpage>439</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://applications.emro.who.int/EMHJ/v22/07/EMHJ_2016_22_07_432_439.pdf"/>
          </comment>
          <pub-id pub-id-type="doi">10.26719/2016.22.7.432</pub-id>
          <pub-id pub-id-type="medline">27714736</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="web">
          <article-title>Yemen population</article-title>
          <source>Worldometer</source>
          <access-date>2020-06-05</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.worldometers.info/world-population/yemen-population/">https://www.worldometers.info/world-population/yemen-population/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="web">
          <article-title>Surveillance, forecasting and response</article-title>
          <source>World Health Organization</source>
          <access-date>2018-10-13</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://www.emro.who.int/surveillance-forecasting-response/pandemic-influenza/pip-yemen.html">http://www.emro.who.int/surveillance-forecasting-response/pandemic-influenza/pip-yemen.html</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Al Amad</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Al Mahaqri</surname>
              <given-names>AA</given-names>
            </name>
            <name name-style="western">
              <surname>Al Serouri</surname>
              <given-names>AA</given-names>
            </name>
            <name name-style="western">
              <surname>Khader</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Severe acute respiratory infections with influenza and noninfluenza respiratory viruses: Yemen, 2011-2016</article-title>
          <source>Inquiry</source>
          <year>2019</year>
          <volume>56</volume>
          <fpage>46958019850731</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/0046958019850731?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/0046958019850731</pub-id>
          <pub-id pub-id-type="medline">31137990</pub-id>
          <pub-id pub-id-type="pmcid">PMC6542124</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Craig</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Kool</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Nilles</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The Pacific experience: supporting small island countries and territories to meet their 2012 International Health Regulations (2005) commitments</article-title>
          <source>Western Pac Surveill Response J</source>
          <year>2013</year>
          <month>07</month>
          <day>03</day>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>14</fpage>
          <lpage>18</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/24319608"/>
          </comment>
          <pub-id pub-id-type="doi">10.5365/WPSAR.2012.3.4.007</pub-id>
          <pub-id pub-id-type="medline">24319608</pub-id>
          <pub-id pub-id-type="pii">WPSAR.2013.4.3-014</pub-id>
          <pub-id pub-id-type="pmcid">PMC3854103</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>German</surname>
              <given-names>RR</given-names>
            </name>
            <name name-style="western">
              <surname>Lee</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Horan</surname>
              <given-names>JM</given-names>
            </name>
            <name name-style="western">
              <surname>Milstein</surname>
              <given-names>RL</given-names>
            </name>
            <name name-style="western">
              <surname>Pertowski</surname>
              <given-names>CA</given-names>
            </name>
            <name name-style="western">
              <surname>Waller</surname>
              <given-names>MN</given-names>
            </name>
            <collab>Guidelines Working Group Centers for Disease Control and Prevention (CDC)</collab>
          </person-group>
          <article-title>Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group</article-title>
          <source>MMWR Recomm Rep</source>
          <year>2001</year>
          <month>07</month>
          <day>27</day>
          <volume>50</volume>
          <issue>RR-13</issue>
          <fpage>1</fpage>
          <lpage>35; quiz CE1-7</lpage>
          <pub-id pub-id-type="medline">18634202</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Simusika</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Tempia</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Chentulo</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Polansky</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Mazaba</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Ndumba</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Mbewe</surname>
              <given-names>QK</given-names>
            </name>
            <name name-style="western">
              <surname>Monze</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>An evaluation of the Zambia influenza sentinel surveillance system, 2011-2017</article-title>
          <source>BMC Health Serv Res</source>
          <year>2020</year>
          <month>01</month>
          <day>13</day>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>35</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-4884-5"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/s12913-019-4884-5</pub-id>
          <pub-id pub-id-type="medline">31931793</pub-id>
          <pub-id pub-id-type="pii">10.1186/s12913-019-4884-5</pub-id>
          <pub-id pub-id-type="pmcid">PMC6958603</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Babakazo</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Kabamba-Tshilobo</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Wemakoy</surname>
              <given-names>EO</given-names>
            </name>
            <name name-style="western">
              <surname>Lubula</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Manya</surname>
              <given-names>LK</given-names>
            </name>
            <name name-style="western">
              <surname>Ilunga</surname>
              <given-names>BK</given-names>
            </name>
            <name name-style="western">
              <surname>Disasuani</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Nkwembe</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Kavunga-Membo</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Changachanga</surname>
              <given-names>JC</given-names>
            </name>
            <name name-style="western">
              <surname>Muhemedi</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Tamfum</surname>
              <given-names>JJM</given-names>
            </name>
            <name name-style="western">
              <surname>Tempia</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the influenza sentinel surveillance system in the Democratic Republic of Congo, 2012-2015</article-title>
          <source>BMC Public Health</source>
          <year>2019</year>
          <month>12</month>
          <day>10</day>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>1652</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-8008-2"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/s12889-019-8008-2</pub-id>
          <pub-id pub-id-type="medline">31823763</pub-id>
          <pub-id pub-id-type="pii">10.1186/s12889-019-8008-2</pub-id>
          <pub-id pub-id-type="pmcid">PMC6902419</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Budgell</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>AL</given-names>
            </name>
            <name name-style="western">
              <surname>McAnerney</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Walaza</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Madhi</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Blumberg</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Dawood</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Kahn</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Tempia</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Venter</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of two influenza surveillance systems in South Africa</article-title>
          <source>PLoS One</source>
          <year>2015</year>
          <month>03</month>
          <day>30</day>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>e0120226</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0120226</pub-id>
          <pub-id pub-id-type="medline">25822719</pub-id>
          <pub-id pub-id-type="pii">PONE-D-14-41364</pub-id>
          <pub-id pub-id-type="pmcid">PMC4379032</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Noreen</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Khan</surname>
              <given-names>AW</given-names>
            </name>
            <name name-style="western">
              <surname>Badar</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Khan</surname>
              <given-names>FK</given-names>
            </name>
            <name name-style="western">
              <surname>Khudaidad</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Khan</surname>
              <given-names>NU</given-names>
            </name>
            <name name-style="western">
              <surname>Riaz</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Malik</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of lab-based influenza surveillance system in Pakistan, 2017</article-title>
          <source>Global Biosecurity</source>
          <year>2019</year>
          <month>07</month>
          <day>03</day>
          <volume>1</volume>
          <issue>2</issue>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://jglobalbiosecurity.com/article/10.31646/gbio.26/"/>
          </comment>
          <pub-id pub-id-type="doi">10.31646/gbio.26</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Li</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names>LJ</given-names>
            </name>
            <name name-style="western">
              <surname>Qin</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Jian</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Li</surname>
              <given-names>ZJ</given-names>
            </name>
            <name name-style="western">
              <surname>Feng</surname>
              <given-names>LZ</given-names>
            </name>
            <name name-style="western">
              <surname>Peng</surname>
              <given-names>ZB</given-names>
            </name>
          </person-group>
          <article-title>Evaluation on data quality of severe acute respiratory infection sentinel surveillance system in China, 2015-2016</article-title>
          <source>Disease Surveillance</source>
          <year>2017</year>
          <volume>32</volume>
          <issue>12</issue>
          <fpage>914</fpage>
          <lpage>916</lpage>
          <pub-id pub-id-type="doi">10.3784/j.issn.1003-9961.2017.12.005</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
